ANO1, CaV1.2, and IP3R form a localized unit of EC-coupling in mouse pulmonary arterial smooth muscle
Authors:
- Elizabeth J. AkinEAElizabeth J. Akin
- Joydeep AounJAJoydeep Aoun
- Connor JimenezCJConnor Jimenez
- Katie MayneKMKatie Mayne
- Julius BaeckJBJulius Baeck
- Michael D. YoungMYMichael D. Young
- Brennan SullivanBSBrennan Sullivan
- Kenton M. SandersKSKenton M. Sanders
- Sean M. WardSWSean M. Ward
- Simon BulleySBSimon Bulley
- Jonathan H. JaggarJJJonathan H. Jaggar
- Scott EarleySEScott Earley
Open Access
- 13 September 2023
- journal article
- research article
- Published by Rockefeller University Press in Journal of General Physiology
- Vol. 155 (11)
Abstract
Pulmonary arterial (PA) smooth muscle cells (PASMC) generate vascular tone in response to agonists coupled to Gq-protein receptor signaling. Such agonists stimulate oscillating calcium waves, the frequency of which drives the strength of contraction. These Ca2+ events are modulated by a variety of ion channels including voltage-gated calcium channels (CaV1.2), the Tmem16a or Anoctamin-1 (ANO1)-encoded calcium-activated chloride (CaCC) channel, and Ca2+ release from the sarcoplasmic reticulum through inositol-trisphosphate receptors (IP3R). Although these calcium events have been characterized, it is unclear how these calcium oscillations underly a sustained contraction in these muscle cells. We used smooth muscle–specific ablation of ANO1 and pharmacological tools to establish the role of ANO1, CaV1.2, and IP3R in the contractile and intracellular Ca2+ signaling properties of mouse PA smooth muscle expressing the Ca2+ biosensor GCaMP3 or GCaMP6. Pharmacological block or genetic ablation of ANO1 or inhibition of CaV1.2 or IP3R, or Ca2+ store depletion equally inhibited 5-HT-induced tone and intracellular Ca2+ waves. Coimmunoprecipitation experiments showed that an anti-ANO1 antibody was able to pull down both CaV1.2 and IP3R. Confocal and superresolution nanomicroscopy showed that ANO1 coassembles with both CaV1.2 and IP3R at or near the plasma membrane of PASMC from wild-type mice. We conclude that the stable 5-HT-induced PA contraction results from the integration of stochastic and localized Ca2+ events supported by a microenvironment comprising ANO1, CaV1.2, and IP3R. In this model, ANO1 and CaV1.2 would indirectly support cyclical Ca2+ release events from IP3R and propagation of intracellular Ca2+ waves.Keywords
Funding Information
- National Institutes of Health (R01HL146054, P20GM130459, R35HL155008, P20GM130459, R01HL146054, HL155180, HL166411, HL158846, R01DK120759)
- British Heart Foundation (FS/18/41/33762)
This publication has 120 references indexed in Scilit:
- Membrane-localized β-subunits alter the PIP 2 regulation of high-voltage activated Ca 2+ channelsProceedings of the National Academy of Sciences, 2012
- TMEM16A Inhibitors Reveal TMEM16A as a Minor Component of Calcium-activated Chloride Channel Conductance in Airway and Intestinal Epithelial CellsJournal of Biological Chemistry, 2011
- Resting State Orai1 Diffuses as Homotetramer in the Plasma Membrane of Live Mammalian CellsJournal of Biological Chemistry, 2010
- Identification of Functionally Segregated Sarcoplasmic Reticulum Calcium Stores in Pulmonary Arterial Smooth MuscleJournal of Biological Chemistry, 2010
- Studies on expression and function of the TMEM16A calcium-activated chloride channelProceedings of the National Academy of Sciences, 2009
- An endoplasmic reticulum/plasma membrane junction: STIM1/Orai1/TRPCsFEBS Letters, 2009
- A role for Orai in TRPC-mediated Ca 2+ entry suggests that a TRPC:Orai complex may mediate store and receptor operated Ca 2+ entryProceedings of the National Academy of Sciences, 2009
- Functional interactions among Orai1, TRPCs, and STIM1 suggest a STIM-regulated heteromeric Orai/TRPC model for SOCE/Icrac channelsProceedings of the National Academy of Sciences, 2008
- Role of InsP3and ryanodine receptors in the activation of capacitative Ca2+entry by store depletion or hypoxia in canine pulmonary arterial smooth muscle cellsBritish Journal of Pharmacology, 2007
- Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategiesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007